Topotecan for ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Topotecan for ovarian cancer

Published:2008-04-16 Issue:7 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Abudou Minawaer¹,Zhong Dake²,Wu Taixiang³,Wu XiaoKe⁴

Affiliation:

1. The Eye Department of the First Affiliated Hospital; Xinjiang Medical University; Xinjiang China

2. Chinese Evidence-Based Medicine Center; West China Hospital, Sichuan University; Chengdu China

3. Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials; West China Hospital, Sichuan University; Chengdu China

4. Department of Obstetrics and Gynaecology; National Key Discipline and Clinical Base, Heilongjiang University of Chinese Medicine; Harbin China

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005589.pub2/epdf/full

Reference93 articles.

1. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.;Bookman;Journal of CLinical Oncology,2009

2. A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma;Judson;Cancer,2008

3. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan;Gordon;Journal Clinical Oncology,2001

4. Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer;Gordon;Gynecologic Oncology,2004

5. Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancer;Gore;Journal Clinical Oncology,2001

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Survival Analysis of Patients with Recurrent Epithelial Ovarian Cancer Based on Relapse Type: A Multi-Institutional Retrospective Study in Armenia;Current Oncology;2024-03-04

2. Molecular mechanisms of cisplatin resistance in ovarian cancer;Genes & Diseases;2023-08

3. Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends;Indian Journal of Medical and Paediatric Oncology;2022-09-29

4. Pharmacotherapeutic treatment options for recurrent epithelial ovarian cancer;Expert Opinion on Pharmacotherapy;2022-08-29

5. Identification of Potential Parkinson’s Disease Drugs Based on Multi-Source Data Fusion and Convolutional Neural Network;Molecules;2022-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3